Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2013 Results
8/13/2013 6:23:13 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NANJING, China, Aug. 13, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended June 30, 2013.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by